Literature DB >> 6326125

Production of platelet-derived growth factor-like molecules and reduced expression of platelet-derived growth factor receptors accompany transformation by a wide spectrum of agents.

D F Bowen-Pope, A Vogel, R Ross.   

Abstract

A series of nontransformed human and murine cells and derivative cell lines transformed by methylcholanthrene; by simian virus 40, Kirsten and Moloney murine sarcoma viruses, simian sarcoma virus, and adenovirus; and by a "spontaneous" event in culture were examined for the expression of receptors for the platelet-derived growth factor (PDGF) and for production of substances able to compete with 125I-labeled PDGF for binding to the cell-surface PDGF receptor. In each case, transformation resulted in a 50-100% decrease in available PDGF receptors. All transformed cells except the methylcholanthrene-transformed mouse cells produce a PDGF competitor into the conditioned medium. Levels of PDGF competitor in conditioned medium at the end of a 48-hr collection were as high as 2 ng/ml--high enough to be measured by radioreceptor assay diluted 1:30 and to maximally stimulate [3H]thymidine incorporation by human fibroblasts. The PDGF competitor activity detected in a radioreceptor assay does not reflect irreversible (e.g., proteolytic) damage to the receptor of test cells since its effects are reversed by acetic acid dissociation. Antiserum against human PDGF neutralizes 20-80% of the PDGF competitor found in conditioned medium from different transformed human cells and 100% of the activity from normal human endothelial cells. The possibility that induction of expression of the cellular PDGF gene may be involved in the mechanism of transformation of PDGF-responsive mesenchymal cells is discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6326125      PMCID: PMC345067          DOI: 10.1073/pnas.81.8.2396

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Transforming viruses directly reduce the cellular growth requirement for a platelet derived growth factor.

Authors:  C D Scher; W J Pledger; P Martin; H Antoniades; C D Stiles
Journal:  J Cell Physiol       Date:  1978-12       Impact factor: 6.384

2.  Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors.

Authors:  G J Todaro; C Fryling; J E De Larco
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

3.  Platelet-derived growth factor. I. High yield purification and evidence for multiple forms.

Authors:  E W Raines; R Ross
Journal:  J Biol Chem       Date:  1982-05-10       Impact factor: 5.157

4.  Similarities between fibroblast-derived growth factor and platelet-derived growth factor.

Authors:  P Dicker; P Pohjanpelto; P Pettican; E Rozengurt
Journal:  Exp Cell Res       Date:  1981-09       Impact factor: 3.905

5.  Chemical and biological properties of a growth factor from human-cultured osteosarcoma cells: resemblance with platelet-derived growth factor.

Authors:  C H Heldin; B Westermark; A Wasteson
Journal:  J Cell Physiol       Date:  1980-11       Impact factor: 6.384

6.  Transforming growth factor(s) production enables cells to grow in the absence of serum: an autocrine system.

Authors:  P L Kaplan; M Anderson; B Ozanne
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

7.  Platelet-derived growth factor. II. Specific binding to cultured cells.

Authors:  D F Bowen-Pope; R Ross
Journal:  J Biol Chem       Date:  1982-05-10       Impact factor: 5.157

8.  Generation of BALB-MuSV and Ha-MuSC by type C virus transduction of homologous transforming genes from different species.

Authors:  P R Andersen; S G Devare; S R Tronick; R W Ellis; S A Aaronson; E M Scolnick
Journal:  Cell       Date:  1981-10       Impact factor: 41.582

9.  Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus.

Authors:  M D Waterfield; G T Scrace; N Whittle; P Stroobant; A Johnsson; A Wasteson; B Westermark; C H Heldin; J S Huang; T F Deuel
Journal:  Nature       Date:  1983 Jul 7-13       Impact factor: 49.962

10.  Platelet-derived growth-factor requirements for in vitro proliferation of normal and malignant mesenchymal cells.

Authors:  G A Currie
Journal:  Br J Cancer       Date:  1981-03       Impact factor: 7.640

View more
  62 in total

1.  A novel functional genomics approach identifies mTERT as a suppressor of fibroblast transformation.

Authors:  Q X Li; J M Robbins; P J Welch; F Wong-Staal; J R Barber
Journal:  Nucleic Acids Res       Date:  2000-07-01       Impact factor: 16.971

2.  Transcriptional activation of the CEF-4/9E3 cytokine gene by pp60v-src.

Authors:  M Dehbi; A Mbiguino; M Beauchemin; G Chatelain; P A Bédard
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

3.  Recent developments in the structure, function and regulation of platelet-derived growth factor and its receptors.

Authors:  J Tiesman; A Rizzino
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

4.  Serum independence of transcription from the promoter of an avian retrovirus in v-src-transformed cells is a primary, intracellular effect of increased tyrosine phosphorylation.

Authors:  A Dutta; M Hamaguchi; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

Review 5.  Platelet-rich plasma and platelet gel: a review.

Authors:  Peter A M Everts; Johannes T A Knape; Gernot Weibrich; Jacques P A M Schönberger; Johannes Hoffmann; Eddy P Overdevest; Henk A M Box; André van Zundert
Journal:  J Extra Corpor Technol       Date:  2006-06

6.  The platelet-derived growth factor alpha-receptor is encoded by a growth-arrest-specific (gas) gene.

Authors:  C J Lih; S N Cohen; C Wang; S Lin-Chao
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

7.  NIH-3T3 cells transformed with a ras oncogene exhibit a protein kinase C-mediated inhibition of agonist-stimulated Ca2+ inflow.

Authors:  A J Polverino; B P Hughes; G J Barritt
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

Review 8.  Mechanisms of transcriptional regulation of cellular genes by SV40 large T- and small T-antigens.

Authors:  U Moens; O M Seternes; B Johansen; O P Rekvig
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

9.  Possible involvement of normal p21 H-ras in the insulin/insulinlike growth factor 1 signal transduction pathway.

Authors:  B M Burgering; A J Snijders; J A Maassen; A J van der Eb; J L Bos
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

10.  Production of platelet-derived growth factorlike protein by rat mesangial cells in culture.

Authors:  H E Abboud; E Poptic; P DiCorleto
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.